Seisa is a medical device manufacturer serving every stage of the product life cycle including design and development, component manufacturing, and final assembly. Seisa delivers with full regulatory compliance.
At Seisa, commitment is central to every partnership. Our primary focus in every area of service is that what we manufacture, what we promise, and what we deliver could change a human life. From our founding, our core tenet has been to hold every employee responsible for adherence to FDA and international regulations. Seisa Group provides a strong portfolio of resources and capabilities to meet your most challenging objectives.
That standard has been maintained from Seisa’s original plant established on the US-Mexico border in 1983, to the 350,000 square feet of manufacturing space we operate today across the globe. With 150,000 square feet of class 7 & 8 cleanroom capacity, 510K generation services, state-of-the-art prototyping and testing technology, and vertically-integrated device manufacturing capabilities, Seisa is fully equipped to provide a broad range of solutions to satisfy our customers’ requirements.
Our success is grounded in our communities. For nearly four decades, Seisa has emphasized the importance of investing in its people. Just as we value the people receiving our products, we value those who make them. In turn, our high retention and stable workforce underpins steady, mass-volume production.
* Hover each location to learn more about its expertise.
As contiguous cities, El Paso and Juarez form a binational metro area that is culturally unique and expert in cross-border trade. With Mexico ranking ninth on the planet and first in Latin America for medical device exports, a group of manufacturing firms have committed to capitalizing on the area’s rich acumen as a global hub for medical manufacturing. The BioMed Cluster unites leaders in academia, research, and manufacturing to boost the region’s economic growth and competitiveness in the medical manufacturing sector. Lower costs for research and development and payroll on the Mexican side of the border offer substantial advantages to businesses based minutes away in the United States.
The Cluster’s board president, Seisa’s founder and CEO, Julio Chiu, brings 30 years’ experience in the field to the group’s administration. The goals and benefits of interdisciplinary collaboration are profound and far-reaching. Among them are access to a stable, qualified, and efficient workforce, expansion of training programs in FDA regulatory compliance and audits, broad support for expediting international permits, leveraging group purchasing for greater supply chain efficiency, and creating a training center for best practices in medical manufacturing. These and other initiatives made possible by Cluster cooperation will foster greater innovation, more clinical studies in Mexico, and increased national investment in the sector. Seisa is proud to be a driving force behind these developments.